spacer
home > epc > media info
MEDIA INFORMATION

Click here to view the EPC media pack

EPC offers an industry-leading platform, which includes:
  • An international readership of pharma and biotech decision makers, plus full-service and speciality CROs, in print
    and online
  • Strong, opinion-led editorial comment and analysis
  • Affiliation with international trade events and conferences
  • An impressive record of long-term advertising partnerships
    and a loyal affiliate network
  • Multimedia presence to reach a global audience
Each edition of EPC runs a number of expert, discussion-based features on the latest contract research and outsourcing moves.
Topics regularly covered include:
  • CRO market analysis
  • Biopharmaceutical development
  • Non-clinical pharmacology/toxicology
  • Laboratory services (bioanalytical labs, central labs)
  • Biosimilars development
  • Biomarkers and assay development
  • Data management
  • Biostatistics
  • Pharmacovigilance
  • Chemistry, manufacturing, controls
  • Strategic and regulatory planning
  • Pricing and market access
  • Contract planning
  • Outsourcing models (eg full service, functional service provider)
  • Supplier selection
  • Managing supplier relationships
  • Procurement practices
  • Technical innovation
  • Business process management
  • CRO performance metrics
spacer



Published quarterly in
February, May,
August, and November
 
Industry Events

CPhI Worldwide

5-7 November 2019, Frankfurt, Germany

Join the World's Largest Pharma Event As it Celebrates its 30th Anniversary! Taking place from 5-7 November 2019 in Frankfurt, Germany, the event will bring together more than 45,000 visiting pharma professionals from around the globe and over 2,500 exhibiting pharma companies from every stage of the pharmaceutical supply chain - from ingredients and machinery to outsourcing services, packaging and more!
More info >>

 
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement